Steroid Analysis pp 1155-1188 | Cite as

Quality Management of Steroid Hormone Assays

  • Jonathan G. MiddleEmail author


This chapter describes the principles and practices of quality management of the steroid hormone in clinical laboratory service, and the assessment of the quality of that service by the author’s EQA programme (UK NEQAS for Steroid Hormones).


Proficiency Test Continuous Quality Improvement External Quality Assessment Internal Quality Control External Quality Assessment Scheme 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The UK NEQAS for Steroid Hormones is funded by subscriptions from participants throughout the UK and overseas. Administrative support is provided by the staff of the Wolfson EQA Laboratory, part of the University Hospital Birmingham NHS Foundation Trust, directed by Dr. David Bullock. Scientific guidance is provided by the UK NEQAS Special Advisory Group for Immunoassay (Chair Dr. Geoff Beckett). Policy support is given by the UK NEQAS Consortium Executive (chair Mrs Barbara De La Salle). UK NEQAS could not function without the support of the National Blood Service at Birmingham, and the work of the Wolfson Computer Laboratory, University Hospital Birmingham NHS Foundation Trust, directed by Dr. Ian Clarke, in developing and maintaining the EQAS Computer System, which is warmly acknowledged.

It should be noted that Siemens Healthcare Medical Solutions have now absorbed Bayer Diagnostics and the Diagnostic Products Corporation. Therefore all references to method names such as Bayer Centaur and DPC Immulite should be understood now to mean Siemens Centaur and Siemens Immulite.


  1. Barnard G, Kohen F (1990) Idiometric assay: noncompetitive immunoassay for small molecules typified by the measurement of oestradiol in serum. Clin. Chem. 36; 1945–1950.Google Scholar
  2. Büttner J (1991) Philosophy of measurement by means of immunoassays. Scand. J. Clin. Lab. Invest. 51 (Suppl 205); 11–20.CrossRefGoogle Scholar
  3. Cawood ML, Field HP, Ford CG, Gillingwater S, Kicman A, Cowan D, Barth JH (2005) Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice. Clin. Chem. 51, 1472–1479.CrossRefGoogle Scholar
  4. de Verdier CH, Groth T, Petersen PH (eds) (1993) Medical Need for quality specifications in clinical laboratories. Upsala J. Med. Sci. 98(3); 189–498.CrossRefGoogle Scholar
  5. Ekins R (1983) The precision profile: its use in assay design, assessment and quality control. In Immunoassays for Clinical Chemistry (eds Hunter WM, Corrie JET). Churchill-Livingstone, Edinburgh. pp. 76–105.Google Scholar
  6. Ekins R (1991a) Immunoassay standardisation. Scand. J. Clin. Lab. Invest. 51(Suppl 205); 33–46.CrossRefGoogle Scholar
  7. Ekins R (1991b) Immunoassay design and optimisation. In Principles and Practice of Immunoassay (eds Price C, Newman D), Chapter 5. Macmillan, London. pp. 96–153.Google Scholar
  8. Ekins RP, Chu R, Biggart E (1990) The development of microspot, multi-analyte, ratiometric immunoassay using dual fluorescent-labelled antibodies. Anal. Chim. Acta. 227; 73–96.CrossRefGoogle Scholar
  9. EU Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices (1998-12-07 OJ No L 331/1).Google Scholar
  10. Fraser CG (1983) Desirable performance standards for clinical chemistry tests. Adv. Clin. Chem. 23; 299–339.CrossRefGoogle Scholar
  11. Fraser CG, Hyltoft-Petersen P (1993a) Desirable standards for laboratory tests if they are to fulfil medical needs. Clin. Chem. 39; 1447–1455.Google Scholar
  12. Fuentes-Aderiu X (2000) Trueness and Uncertainty website guest essay at
  13. Gosling JP (1991) Standardisation of immunoassays for Hapten analytes. Scand. J. Clin. Lab. Invest. 51 (Suppl 205); 95–104.CrossRefGoogle Scholar
  14. Gosling JP, Middle JG, Siekmann L, Read GF (1993) Standardisation of Hapten immunoprocedures: total cortisol. Scand. J. Clin. Lab. Invest. 53 (Suppl 216); 3–41.CrossRefGoogle Scholar
  15. Hammond GL (1990) Molecular properties of corticosteroid binding globulin and the sex steroid binding proteins. Endocr.Rev. 11; 65–79.CrossRefGoogle Scholar
  16. Healy MJR (1979) Outliers in clinical chemistry quality control schemes. Clin. Chem. 25; 675–677.Google Scholar
  17. Herold DA, Fitzgerald RL (2003) Immunoassays for testosterone in women: better than a guess? Clin. Chem. 49; 1250–1251.CrossRefGoogle Scholar
  18. Hyltoft Petersen P, Horder M (1992) Influence of analytical quality on test results. Scand. J. Clin. Lab. Invest. 52 (Suppl 208); 65–67.CrossRefGoogle Scholar
  19. Jeffcoate SL (1981) Efficiency and Effectiveness in the Clinical Laboratory. Academic, London.Google Scholar
  20. Kane J, Middle J, Cawood M (2007) Measurement of serum testosterone in women; what should we do? Ann. Clin. Biochem. 44; 5–15.CrossRefGoogle Scholar
  21. Kushnir MM, Rockwood AL, Roberts WL, Pattison EG, Bunker AM, Fitzgerald RL, and Meikle AW (2006) Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clin. Chem. 52; 120–128.CrossRefGoogle Scholar
  22. Libeer J-CPM (1993) External Quality Assessment in Clinical Laboratories – European perspectives: today and tomorrow. Ph.D. thesis, University of Antwerp, Belgium.Google Scholar
  23. Middle JG (1998) Standardisation of steroid hormone assays. Ann. Clin. Biochem. 35; 354–363.CrossRefGoogle Scholar
  24. Middle JG (2007) Dehydroepiandrostenedione sulphate interferes in many direct immunoassays for testosterone. Ann. Clin. Biochem. 44; 173–177.CrossRefGoogle Scholar
  25. Middle JG, Libeer JC, Malakhov V, Penttilä I (1998) Characterisation and evaluation of external quality assessment scheme serum. Discussion Paper from the European External Quality Assessment (EQA) Organisers Working Group C. Clin. Chem. Lab. Med. 36; 119–130.CrossRefGoogle Scholar
  26. Panteghini M (2007) Traceability, reference systems and result comparability. Clin. Biochem. Rev. 28; 97–104.Google Scholar
  27. Ratcliffe WA, Carter GD, Dowsett M, Hillier SG, Middle JG, Reed MJ (1988) Oestradiol assays: applications and guidelines for the provision of a clinical biochemistry service. Ann. Clin. Biochem. 25; 466–483.CrossRefGoogle Scholar
  28. Ricos C, Arbos MA (1990) Quality goals for hormone testing. Ann. Clin. Biochem. 27; 353–358.CrossRefGoogle Scholar
  29. Ricós C, Iglesias N, García-Lario JV, Simón M, Cava F, Hernández A, Perich C, Minchinela J, Alvarez V, Doménech MV, Jiménez CV, Biosca C, Tena R (2007) Within-subject biological variation in disease: collated data and clinical consequences. Ann. Clin. Biochem. 44; 343–352.CrossRefGoogle Scholar
  30. Ritchie RF (1991) Immunoanalytical standardization – a global science. Scand. J. Clin. Lab. Invest. Suppl. 205; 3–10.CrossRefGoogle Scholar
  31. Selby C (1990) Sex hormone binding globulin: origin, function and clinical significance. Ann. Clin. Biochem. 27; 532–541.CrossRefGoogle Scholar
  32. Seth J, Hanning I (1988) Factors associated with the quality of laboratory performance in the United Kingdom external quality assessment scheme for serum growth hormone. Clin. Chim. Acta. 174; 185–196.CrossRefGoogle Scholar
  33. Stanczyk FZ, Lee JS, Santen RJ. (2007) Standardization of steroid hormone assays: why, how, and when? Cancer Epidemiol. Biomarkers Prev. Sep; 16(9);1713–1719.CrossRefGoogle Scholar
  34. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P (2003) Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin. Chem. 49; 1381–1395.CrossRefGoogle Scholar
  35. Thienpont LM, Van Uytfanghe K, De Leenheer AP (2002) Reference measurement systems in clinical chemistry. Clin. Chim. Ada. 323; 73–87.CrossRefGoogle Scholar
  36. Westgard JO, Darcy T (2004) The truth about quality: medical usefulness and analytical reliability of laboratory tests. Clin. Chim. Acta. 346; 3–11.CrossRefGoogle Scholar
  37. Westgard JO, Petersen JH, Groth T (1984) The quality costs of an analytical process: development of quality costs models based on predicitive value theory. Scand. J. Clin. Lab. Invest. 44(Suppl 172); 221–236.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.UK NEQAS, University Hospital Birmingham NHS Foundation TrustBirminghamUK

Personalised recommendations